Co-Diagnostics IncNASDAQ:CODX
- LAST PRICE1.0594
- TODAY'S CHANGE (%)-0.0006 (-0.0566%)
- Bid / Lots1.0500/ 21
- Ask / Lots1.0600/ 7
- Open / Previous Close1.0500 / 1.0600
- Day Range
- 52 Week Range
- Volume223,943
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | CODX |
|---|---|---|
| 09:32 ET | 3758 | 1.04 |
| 09:35 ET | 300 | 1.0452 |
| 09:37 ET | 2537 | 1.05 |
| 09:42 ET | 326 | 1.0684 |
| 09:46 ET | 1000 | 1.0685 |
| 09:50 ET | 453 | 1.06 |
| 09:55 ET | 2737 | 1.065 |
| 09:57 ET | 5538 | 1.05 |
| 10:00 ET | 101 | 1.0599 |
| 10:08 ET | 6818 | 1.06 |
| 10:18 ET | 7592 | 1.055 |
| 10:26 ET | 200 | 1.05 |
| 10:33 ET | 1568 | 1.06 |
| 10:47 ET | 2300 | 1.0512 |
| 10:49 ET | 1000 | 1.0536 |
| 10:51 ET | 4000 | 1.055 |
| 10:54 ET | 1000 | 1.0507 |
| 11:00 ET | 115 | 1.05 |
| 11:02 ET | 7856 | 1.06 |
| 11:05 ET | 1000 | 1.05 |
| 11:16 ET | 121 | 1.0501 |
| 11:18 ET | 198 | 1.0599 |
| 11:21 ET | 10430 | 1.05 |
| 11:27 ET | 23553 | 1.01 |
| 11:34 ET | 451 | 1.03 |
| 11:36 ET | 100 | 1.035 |
| 11:43 ET | 100 | 1.035 |
| 11:50 ET | 100 | 1.0392 |
| 11:52 ET | 1450 | 1.03 |
| 11:54 ET | 2910 | 1.02 |
| 11:56 ET | 4000 | 1.0292 |
| 11:57 ET | 4000 | 1.0298 |
| 11:59 ET | 28714 | 1.03 |
| 12:03 ET | 17100 | 1.02 |
| 12:06 ET | 300 | 1.025 |
| 12:08 ET | 120 | 1.025 |
| 12:10 ET | 8258 | 1.02 |
| 12:12 ET | 403 | 1.0199 |
| 12:15 ET | 3990 | 1.02 |
| 12:17 ET | 5700 | 1.02 |
| 12:19 ET | 100 | 1.015 |
| 12:21 ET | 5794 | 1.0169 |
| 12:24 ET | 17693 | 1.035 |
| 12:26 ET | 436 | 1.04 |
| 12:32 ET | 1200 | 1.045 |
| 12:37 ET | 100 | 1.04 |
| 12:44 ET | 530 | 1.051 |
| 12:50 ET | 200 | 1.06 |
| 12:51 ET | 198 | 1.0522 |
| 01:04 ET | 300 | 1.06 |
| 01:08 ET | 1200 | 1.0599 |
| 01:20 ET | 1000 | 1.0594 |
Nov 11, 2024
DJ Co-Diagnostics Price Target Maintained With a $1.50/Share by HC Wainwright & Co., from 6:55AM ET on Monday Nov 11, 2024 by Dow Jones
6:55AM ET on Monday Nov 11, 2024 by Dow Jones
Nov 7, 2024
Co-Diagnostics, Inc. Reports Third Quarter 2024 Financial Results, from 4:01PM ET on Thursday Nov 07, 2024 by Dow Jones
4:01PM ET on Thursday Nov 07, 2024 by Dow Jones*DJ Co-Diagnostics 3Q Loss/Shr 32c >CODX, from 4:01PM ET on Thursday Nov 07, 2024 by Dow Jones
4:01PM ET on Thursday Nov 07, 2024 by Dow Jones
Nov 5, 2024
Co-Diagnostics, Inc. to Host Booth at MEDICA Trade Fair in D sseldorf, Germany on Nov 11-14, 2024, from 9:30AM ET on Tuesday Nov 05, 2024 by Dow Jones
9:30AM ET on Tuesday Nov 05, 2024 by Dow Jones
Oct 25, 2024
Co-Diagnostics, Inc. Announces Third Quarter 2024 Earnings Release Date and Webcast, from 4:01PM ET on Friday Oct 25, 2024 by Dow Jones
4:01PM ET on Friday Oct 25, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Co-Diagnostics Inc | 33.8M | -0.8x | --- |
Icecure Medical Ltd | 30.1M | -2.0x | --- |
T2 Biosystems Inc | 10.5M | 0.0x | --- |
Renalytix PLC | 32.7M | -0.2x | --- |
Neuroone Medical Technologies Corp | 21.9M | -1.4x | --- |
Medite Cancer Diagnostics Inc | 90.0 | 0.0x | --- |
Company Information
Co-Diagnostics, Inc. is a molecular diagnostics company, which develops, manufactures and markets diagnostics technologies. The Company’s technologies are utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR platform and to locate genetic markers for use in applications other than infectious disease. Its diagnostics systems enable dependable, low-cost, molecular testing for organisms and genetic diseases by automating or simplifying historically complex procedures in both the development and administration of tests. It is developing a portable diagnostic device and test system designed for point-of-care and at-home use. The system consists of its PCR instrument that it refers to as the Co-Dx PCR Pro instrument, its proprietary diagnostic test cup system and a mobile application to be installed on the user’s mobile device.
Contact Information
- Headquarters
- 4049 S Highland DrSALT LAKE CITY, UT, United States 84124-1664
- Phone
- 801-278-9769
- Fax
- ---
Executives
- Chairman of the Board, Chief Executive Officer
- Dwight Egan
- President
- Richard Abbott
- Chief Financial Officer, Company Secretary
- Brian Brown
- Chief Operations Officer
- David Nielsen
- Chief Technology Officer
- Christopher Thurston
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $33.8M |
|---|---|
Revenue (TTM) | $7.3M |
Shares Outstanding | 31.9M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | -0.85 |
EPS | $-1.38 |
Book Value | $2.75 |
P/E Ratio | -0.8x |
Price/Sales (TTM) | 4.6 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -549.79% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
